BioXcel Therapeutics Announces European Patent Office's Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
Stock Information for BioXcel Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.